{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:02:16Z","timestamp":1759773736623},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3933,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1111\/j.1523-1755.2005.00183.x","type":"journal-article","created":{"date-parts":[[2005,2,7]],"date-time":"2005-02-07T19:10:13Z","timestamp":1107803413000},"page":"1161-1170","source":"Crossref","is-referenced-by-count":18,"title":["Intravenous iron preparations and ascorbic acid: Effects on chelatable and bioavailable iron"],"prefix":"10.1016","volume":"67","author":[{"given":"Brigitte","family":"Sturm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Laggner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Ternes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Scheiber-Mojdehkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/13.1.82","article-title":"Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0015","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder-Plassmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0025","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","article-title":"A distinct balance: The safety and efficacy of parenteral iron therapy","volume":"10","author":"Besarab","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 5","key":"10.1111\/j.1523-1755.2005.00183.x_bb0030","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/ndt\/16.suppl_5.50","article-title":"Present and future strategies in the treatment of renal anemia","volume":"16","author":"Macdougall","year":"2001","journal-title":"Nephrol Dial Trans"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","article-title":"Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury","volume":"40","author":"Tager","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0040","first-page":"1439","article-title":"Structure\/histotoxicity relationship of parenteral iron","volume":"42","author":"Geisser","year":"1992","journal-title":"Drug Res"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1067\/mlc.2000.110368","article-title":"Treatment of iron deficiency anemia: Are monomeric iron compounds suitable for parenteral administration?","volume":"136","author":"Gupta","year":"2000","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0050","first-page":"615","article-title":"Pharmacokinetics of iron (III)-sucrose complex after a single intravenous dose in healthy volunteers","volume":"46","author":"Danielson","year":"1996","journal-title":"Drug Res"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0272-6386(95)90105-1","article-title":"Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin","volume":"25","author":"Wingard","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0060","first-page":"141","article-title":"Erythropoietin and iron","volume":"47","author":"Sunder-Plassmann","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0065","first-page":"81","article-title":"Role of transferrin measurement in monitoring iron status during recombinant human erythropoietin therapy","volume":"21","author":"Rosemberg","year":"1992","journal-title":"Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1523-1755.1999.00627.x","article-title":"Factors determining the percentage of hypochromic red blood cells in hemodialysis patients","volume":"56","author":"Bovy","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ndt\/14.3.659","article-title":"Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis","volume":"14","author":"Cullen","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V75.1.102.102","article-title":"Intact transferrin receptors in human plasma and their relation to erythropoiesis","volume":"75","author":"Huebers","year":"1990","journal-title":"Blood"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1525-1594.2002.06888.x","article-title":"Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients","volume":"26","author":"Sezer","year":"2001","journal-title":"Artif Organs"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000070991","article-title":"Vitamin C in chronic kidney disease and hemodialysis patients","volume":"26","author":"Deicher","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0095","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.86.16.6377","article-title":"Ascorbate is an outstanding antioxidant in human blood plasma","volume":"86","author":"Frei","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0100","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","article-title":"Antioxidant defenses and lipid peroxidation in human blood plasma","volume":"85","author":"Frei","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/bj2770133","article-title":"Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid","volume":"277","author":"Frei","year":"1991","journal-title":"Biochem J"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.296.6629.1081","article-title":"Oral iron chelating drugs: Coming but not yet ready for clinical use","volume":"296","author":"Hershko","year":"1988","journal-title":"BMJ"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0968-0004(99)01418-8","article-title":"Poison, prophylactic or panacea?","volume":"24","author":"Halliwell","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0272-6386(03)00419-0","article-title":"Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: Influence of serum ferritin levels","volume":"42","author":"Chen","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0125","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1152\/ajpendo.2000.279.6.E1406","article-title":"Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload","volume":"279","author":"Chen","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10715769709097844","article-title":"Effects of co-supplementation of iron with ascorbic acid onantioxidant-pro-oxidant balance in the guinea pig","volume":"27","author":"Collis","year":"1997","journal-title":"Free Radic Res"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI7664","article-title":"Iron overload diminishes atherosclerosis in apoE-deficient mice","volume":"107","author":"Kirk","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.ejcn.1600730","article-title":"Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers?","volume":"53","author":"Yang","year":"1999","journal-title":"Eur J Clin Nutr"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0145","doi-asserted-by":"crossref","first-page":"15656","DOI":"10.1006\/bbrc.2000.3711","article-title":"Potential problems of ascorbate and iron supplementations: Pro-oxidant effect in vivo?","volume":"277","author":"Proteggente","year":"2000","journal-title":"Biochem Bioph Res Comm"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1523-1755.2004.00809.x","article-title":"Protective effect of vitamin C on 8-hydroxy-2\u2032-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients","volume":"66","author":"Tarng","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0155","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1016\/0304-4165(80)90028-8","article-title":"Rapid mobilization of ferritin iron by ascorbate in the presence of oxygen","volume":"631","author":"Bienfait","year":"1980","journal-title":"Biochem Biophys Acta"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0160","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/ndt\/13.11.2867","article-title":"A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in haemodialysis patients with iron overload","volume":"13","author":"Tarng","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0165","doi-asserted-by":"crossref","first-page":"15656","DOI":"10.1074\/jbc.272.25.15656","article-title":"Antioxidant activity of vitamin C in iron-overloaded human plasma","volume":"272","author":"Berger","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0170","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1046\/j.1432-1033.2003.03759.x","article-title":"Transient increase of the labile iron pool in HepG2 cells by intravenous iron preparations","volume":"270","author":"Sturm","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/abio.2001.5378","article-title":"A fluorescence-based one-step assay for serum non-transferrin-bound iron","volume":"299","author":"Breuer","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0185","doi-asserted-by":"crossref","first-page":"24209","DOI":"10.1074\/jbc.270.41.24209","article-title":"Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron","volume":"270","author":"Breuer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0190","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0006-2952(03)00181-3","article-title":"Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells","volume":"65","author":"Scheiber-Mojdehkar","year":"2003","journal-title":"Biochem Pharm"},{"issue":"Suppl 6","key":"10.1111\/j.1523-1755.2005.00183.x_bb0195","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/ndt\/10.supp6.44","article-title":"Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration","volume":"10","author":"Gastaldello","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0200","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/ndt\/gfh260","article-title":"Vitamin C plasma level and response to erythropoietin in patients on maintainance haemodialysis","volume":"19","author":"Deicher","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0205","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1016\/S0021-9258(18)67014-0","article-title":"The effects of ascorbic acid on the intracellular metabolism of iron and ferritin","volume":"261","author":"Bridges","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.1971.tb07024.x","article-title":"The role of ascorbic acid in the metabolism of storage iron","volume":"20","author":"Lipschitz","year":"1971","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0215","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/ajcn\/23.10.1339","article-title":"Ascorbic acid depletion in patients undergoing chronic hemodialysis","volume":"23","author":"Sullivan","year":"1970","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.0954-6820.1983.tb03739.x","article-title":"Serum ascorbic acid in patients undergoing chronic hemodialysis","volume":"213","author":"Ponka","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0225","first-page":"26","article-title":"Routine vitamin therapy for the dialysis patient: Current concerns","volume":"16","author":"Cotton","year":"1995","journal-title":"Contemp Dial Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0230","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1681\/ASN.V7112320","article-title":"Secondary oxalosis: A cause of delayed recovery of renal function in the setting of acute renal failure","volume":"7","author":"Alkhunaizi","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0235","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.V1121289","article-title":"Plasma oxalate levels in hemodialysis patients despite increased oxalate removal","volume":"1","author":"Costello","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10715769609149066","article-title":"Antioxidant or pro-oxidant in vivo?","volume":"25","author":"Halliwell","year":"1996","journal-title":"Free Radic Res"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0003-9861(86)90305-X","article-title":"Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts","volume":"246","author":"Halliwell","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-1755.2004.00716.x","article-title":"Parenteral iron nephrotoxicity: Potential mechanisms and consequences","volume":"66","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00183.x_bb0255","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1365-2362.2003.01264.x","article-title":"Effect of iron sucrose on human peritoneal mesothelial cells","volume":"33","author":"Breborowicz","year":"2003","journal-title":"Eur J Clin Invest"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815505644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815505644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:04:45Z","timestamp":1625432685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815505644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0085253815505644"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00183.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}